Clinical Trials Sponsored by Laboratoires NEGMA
Total 2150 results
-
Braintree LaboratoriesCompletedColon CancerUnited States
-
Materna LaboratoriesCompleted
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Forest LaboratoriesWithdrawnCommunity-Acquired Bacterial Pneumonia (CABP)
-
Braintree LaboratoriesCompleted
-
Braintree LaboratoriesCompleted
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompletedStage 2 Diastolic HypertensionUnited States, Puerto Rico
-
Forest LaboratoriesCompletedAlzheimer's DiseaseUnited States
-
Forest LaboratoriesCompletedDyspepsiaUnited States
-
Forest LaboratoriesCompletedAlzheimer's DiseaseUnited States
-
Forest LaboratoriesCompletedAtrial FibrillationGermany, France, Belgium, Hungary, Italy, Netherlands, Poland, Russian Federation, Spain
-
Forest LaboratoriesCompletedAtrial FibrillationUnited States, Canada
-
Forest LaboratoriesCompletedHypertension | Type 2 Diabetes MellitusUnited States, Puerto Rico
-
Winston LaboratoriesCompleted
-
Braintree LaboratoriesCompletedColonoscopy | Bowel PreparationUnited States
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompletedAlzheimer's DiseaseAustralia, New Zealand, South Africa
-
Braintree LaboratoriesCompletedConstipationUnited States
-
Braintree LaboratoriesCompletedConstipationUnited States
-
Summers LaboratoriesCompleted
-
Northfield LaboratoriesUnknownHemorrhagic ShockUnited States
-
Laboratoire ChauvinCompleted
-
Laboratoires Coloplast S.A.SRecruiting
-
Laboratoires Mayoly SpindlerCompletedIrritable Bowel Syndrome
-
Laboratoires Bouchara-RecordatiUnknown
-
Laboratoires Besins InternationalUnknown
-
Laboratoires Mayoly SpindlerCompleted
-
bioLytical LaboratoriesNot yet recruitingHuman Immunodeficiency Virus I Infection | Human Immunodeficiency Virus II Infection
-
Beker LaboratoriesActive, not recruiting
-
Braintree LaboratoriesEnrolling by invitationA Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseNon-erosive Reflux Disease | Erosive EsophagitisUnited States
-
Braintree LaboratoriesTerminatedPerianal Crohn's DiseaseUnited States
-
Braintree LaboratoriesCompleted
-
bioLytical LaboratoriesCompletedCOVID-19 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19United States
-
Braintree LaboratoriesCompletedChronic Idiopathic ConstipationUnited States
-
Braintree LaboratoriesCompletedConstipationUnited States
-
Forest LaboratoriesCompleted
-
Forest LaboratoriesCompletedDepression | Major Depressive DisorderUnited States, Canada
-
Forest LaboratoriesCompletedGeneralized Anxiety DisorderUnited States
-
United LaboratoriesCompletedSkin Aging | WrinklesPhilippines
-
United LaboratoriesCompletedPediculosis CapitisPhilippines
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States
-
Forest LaboratoriesCompleted
-
Forest LaboratoriesTerminatedNeoplasms | Febrile NeutropeniaUnited States
-
Forest LaboratoriesCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Forest LaboratoriesCompletedCystic Fibrosis | Pancreatic InsufficiencyUnited States
-
Forest LaboratoriesCompletedCystic Fibrosis | Exocrine Pancreatic InsufficiencyUnited States
-
Forest LaboratoriesCompletedChronic Pancreatitis | Exocrine Pancreatic Insufficiency | PancreatectomyCanada, United States, Poland, Slovakia